Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dantrolene in Statin-induced Myopathy
NCT06966843Phase 3Not yet recruiting
- Sponsor
- Tanta University
- Start
- Oct 2027
- Primary completion
- Jan 2029
- Modality
- Classical Binding Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in statin-induced myopathy comparing Dantrolene Group with Placebo Group (2 arms). Primary endpoint: Change in Creatine Kinase Level at 4 weeks. Planned start Oct 2027; status: not yet recruiting.
02
Drugs
dantrolene
03
Conditions
statin-induced myopathy
Beyond the preview
Go deeper on NCT06966843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06966843.